Orbits is a pioneering healthtech company founded in 2022 with a mission to revolutionize cancer drug development by putting patients at the center of the process. With a focus on early-stage cancer research and personalized medicine, Orbits combines clinical data, patient-centric platforms, and biotech partnerships to accelerate the discovery and delivery of targeted treatments. By bridging the gap between patients and researchers, the company aims to make cancer therapies more effective, faster to develop, and tailored to individual needs.